Singapore, 13 September 2022 (GLOBE NEWSWIRE) –

  • AMTH has acquired the Chinese market leader in urology and shockwave therapy devices
  • Acquisition expands Advanced MedTech’s urology market access in China through a comprehensive nationwide sales and service network and an established local R&D, manufacturing and supply chain ecosystem
  • The acquisition provides Advanced MedTech with an emerging market medical device platform that aligns with China’s local medical device manufacturing strategy. It will serve domestic demand in China, the second largest and fastest growing healthcare market in the world, and will supply other global emerging markets.

Integrated urology leader Advanced MedTech Holdings (AMTH or the Group) has announced the acquisition of a majority stake in WIKKON, the Chinese market leader in urology and shockwave therapy devices. AMTH expects to acquire the remaining shares of WIKKON by the end of 2022. Based in the technology hub of Shenzhen, also known as China’s Silicon Valley, WIKKON specializes in the development and manufacture of solutions for the treatment of urological and orthopedic conditions such as kidney stones, erectile dysfunction and joint, muscle or tissue pain.

Founded in 1996, WIKKON has the largest installed base of more than 6,000 urological treatment devices in China and strong relationships with healthcare professionals. The acquisition will significantly strengthen AMTH’s direct presence in China.

By combining the German engineering strength of Dornier MedTech, the wholly owned subsidiary of AMTH, with the innovative capabilities of WIKKON, AMTH will be able to offer clinicians access to an expanded product portfolio and build a high potential platform for development. of a segment of global value in urology.

With China’s focus on domestic sourcing of key medical devices and its sizable domestic market, AMTH is well positioned to meet the expanded needs of the world’s second largest and fastest growing healthcare market with deeper localization of capabilities. research and development and production. WIKKON products are used in more than 40 countries in Asia Pacific and the rest of the world, giving AMTH a solid platform to better meet the needs of global emerging markets from WIKKON’s base in Shenzhen.

Abel Ang, Group Chief Executive of Advanced MedTech, said: “We are now in a unique position to aggressively grow in the vast Chinese market, which is best served by domestically manufactured devices. Advanced MedTech’s integrated urology platform is accelerated by WIKKON’s important R&D, manufacturing, supply chain and installed base of units. Our newly combined portfolio will enable us to serve urology customers seeking value-oriented solutions to premium-oriented customers globally. ”

Chen Ming, Founder and President of WIKKON, said: “We are thrilled to be joining the Advanced MedTech group. By combining our expertise in innovative technology, research and reach, we will be able to significantly expand our solutions to healthcare professionals around the world. ”


About Advanced MedTech Holdings
Advanced MedTech Holdings is a global leader in medical technology with a primary focus on urology devices and contract manufacturing services. The Group serves millions of patients and doctors in 100 countries around the world. Advanced MedTech Holdings makes strategic investments in disruptive medical technology companies, strengthening its portfolio of healthcare solutions for clients around the world. Advanced MedTech Holdings is a wholly owned subsidiary of Temasek.
For more information visit

About Dornier MedTech
Dornier MedTech is a medical device company headquartered in Munich, Germany, and is a wholly owned subsidiary of Advanced MedTech. As a pioneer of the shock wave lithotripsy method and a leader in urological care, Dornier is one of the most trusted names in the industry. Through its ingrained entrepreneurial spirit and excellence, Dornier continues to lead innovation in urology, developing some of the highest quality urological devices on the market today. Given its wide range of customers, Dornier is a leader in technology and improves life around the world.
For more information visit

WIKKON (Shenzhen Wikkon Precision Instruments Co., Ltd.) is a high and new technology enterprise with medical device research, engineering and manufacturing capabilities, headquartered in Shenzhen, China. Founded in 1996, WIKKON is dedicated to innovation in the field of extracorporeal shock wave lithotripsy (ESWL) for kidney stone removal, extracorporeal shock wave therapy (ESWT) for erectile dysfunction and joint pain relief and Urology Imaging Table for all uses of medical exams and procedures.
For more information visit


Leave a Reply

%d bloggers like this: